Company Name or Ticker Symbol
Search for other Categories

Orgenesis Inc.  (ORGS)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

ORGS's Revenue Year on Year Growth by Quarter and Year

Orgenesis's Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
ORGS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter November - 6.39 1.22 -
III Quarter August - - 0.94 -
II Quarter May - - 0.82 -
I Quarter February 1.85 - - -
FY   1.85 6.39 2.98 -

Financial Statements
Orgenesis's first quarter 2017 Revenue $ 1.85 millions ORGS's Income Statement
Orgenesis's first quarter 2016 Revenue $ 0.00 millions Quarterly ORGS's Income Statement
ORGS's Growth by Division See ORGS's Growth by Segment

ORGS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter November - 423.77 % - -
III Quarter August - - - -
II Quarter May - - - -
I Quarter February - - - -
FY   - 114.43 % - -

ORGS Revenue Growth Comment
Orgenesis Inc. in the first quarter achieved Revenue of $ 1.85 millions compare to recorded in same quarter a year ago.

Among companies who have reported first quarter results in the Biotechnology & Drugs industry only one Company has achieved higher year on year Revenue results in the first quarter. While Orgenesis Inc.' s Revenue no change of % ranks overall at the positon no. 10 in the first quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #2
Healthcare Sector #3
S&P 500 #10
Revenue Y/Y Growth Statistics
High Average Low
121742.11 % 30491.89 % -99.86 %
(Feb 28 2017)   (May 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ORGS's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ORGS's Competitors
Revenue Growth for Orgenesis's Suppliers
Revenue Growth for ORGS's Customers

You may also want to know
ORGS's Annual Growth Rates ORGS's Profitability Ratios ORGS's Asset Turnover Ratio ORGS's Dividend Growth
ORGS's Roe ORGS's Valuation Ratios ORGS's Financial Strength Ratios ORGS's Dividend Payout Ratio
ORGS's Roa ORGS's Inventory Turnover Ratio ORGS's Growth Rates ORGS's Dividend Comparisons

Companies with similar Revenue no change for the quarter ending Feb 28 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Feb 28 2017
Walgreens Boots Alliance, Inc. -2.45 %$ -2.445 millions
Repro Med Systems Inc -10.38 %$ -10.383 millions
Lescarden Inc -64.31 %$ -64.307 millions
Cannabics Pharmaceuticals Inc. -90.06 %$ -90.056 millions

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com